中国农村基于初级保健的移动健康综合干预对卒中管理的效果:SINEMA整群随机对照试验
在中国河北农村50个村开展整群随机对照试验,纳入1299例卒中患者,评估基于村医的移动健康综合干预(SINEMA)与常规照护相比的效果。12个月时干预组收缩压较对照组多降低2.8 mm Hg(95%CI -4.8, -0.9;p=0.005),并在舒张压、生活质量、体力活动、他汀和降压药依从性及起立行走测试等多项次要结局上显著改善。
要点
- SINEMA干预使农村卒中患者12个月收缩压多降低2.8 mm Hg(95%CI -4.8, -0.9)。
- 干预组舒张压、生活质量、体力活动、他汀及降压药依从性均显著改善。
- 探索性结局中卒中复发、住院、残疾和死亡风险均降低。
核心结论
- 基于初级保健、整合供方与患者端技术的移动健康干预可有效降低农村卒中患者血压并改善二级预防。
研究设计与样本
- 社区为基础、两臂、整群随机对照试验,结局评估设盲,在中国河北农村50个村开展。
- 2017年6月23日至7月21日招募1299例卒中患者,平均年龄65.7岁(SD 8.2),女性42.6%,71.2%教育程度低于小学。
- 村庄按1:1随机分配至干预组或对照组(常规照护),所有村庄完成12个月随访,干预组611例和对照组615例患者成功随访。
主要发现
- 主要结局12个月收缩压变化:干预组较对照组调整后平均差为-2.8 mm Hg(95%CI -4.8, -0.9;p=0.005)。
- 7项次要结局中6项显著改善:舒张压(p<0.001)、健康相关生活质量(p=0.008)、体力活动(p<0.001)、他汀依从性(p=0.003)、降压药依从性(p=0.039)、起立行走测试(p=0.022)。
- 探索性结局:卒中复发4.4% vs 9.3%(RR=0.46,95%CI 0.32, 0.66;RD=4.9个百分点)。
- 探索性结局:住院4.4% vs 9.3%(RR=0.45,95%CI 0.32, 0.62;RD=4.9个百分点)。
- 探索性结局:残疾20.9% vs 30.2%(RR=0.65,95%CI 0.53, 0.79;RD=9.3个百分点);死亡1.8% vs 3.1%(RR=0.52,95%CI 0.28, 0.96;RD=1.3个百分点)。
关键数值与推荐
- 干预组村医接受培训,使用基于安卓的移动应用进行每月随访,并获得基于绩效的报酬。
- 干预组患者接受每月医生访视和每日自动语音信息。
- 项目执行保真度高,年人均项目交付成本为24.3美元。
临床怎么用
- 在资源有限的农村地区,可依托村医和移动健康技术开展卒中二级预防管理。
- 干预包含医生随访、患者语音提醒和绩效激励,具有可操作性。
局限性
- 研究持续时间仅1年,相对较短。
- 研究结果在研究环境之外的推广性有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Managing noncommunicable diseases through primary healthcare has been identified as the key strategy to achieve universal health coverage but is challenging in most low- and middle-income countries. Stroke is the leading cause of death and disability in rural China. This study aims to determine whether a primary care-based integrated mobile health intervention (SINEMA intervention) could improve stroke management in rural China. METHODS AND FINDINGS: Based on extensive barrier analyses, contextual research, and feasibility studies, we conducted a community-based, two-arm cluster-randomized controlled trial with blinded outcome assessment in Hebei Province, rural Northern China including 1,299 stroke patients (mean age: 65.7 [SD:8.2], 42.6% females, 71.2% received education below primary school) recruited from 50 villages between June 23 and July 21, 2017. Villages were randomly assigned (1:1) to either the intervention or control arm (usual care). In the intervention arm, village doctors who were government-sponsored primary healthcare providers received training, conducted monthly follow-up visits supported by an Android-based mobile application, and received performance-based payments. Participants received monthly doctor visits and automatically dispatched daily voice messages. The primary outcome was the 12-month change in systolic blood pressure (BP). Secondary outcomes were predefined, including diastolic BP, health-related quality of life, physical activity level, self-reported medication adherence (antiplatelet, statin, and antihypertensive), and performance in "timed up and go" test. Analyses were conducted in the intention-to-treat framework at the individual level with clusters and stratified design accounted for by following the prepublished statistical analysis plan. All villages completed the 12-month follow-up, and 611 (intervention) and 615 (control) patients were successfully followed (3.4% lost to follow-up among survivors). The program was implemented with high fidelity, and the annual program delivery cost per capita was US$24.3. There was a significant reduction in systolic BP in the intervention as compared with the control group with an adjusted mean difference: -2.8 mm Hg (95% CI -4.8, -0.9; p = 0.005). The intervention was significantly associated with improvements in 6 out of 7 secondary outcomes in diastolic BP reduction (p < 0.001), health-related quality of life (p = 0.008), physical activity level (p < 0.001), adherence in statin (p = 0.003) and antihypertensive medicines (p = 0.039), and performance in "timed up and go" test (p = 0.022). We observed reductions in all exploratory outcomes, including stroke recurrence (4.4% versus 9.3%; risk ratio [RR] = 0.46, 95% CI 0.32, 0.66; risk difference [RD] = 4.9 percentage points [pp]), hospitalization (4.4% versus 9.3%; RR = 0.45, 95% CI 0.32, 0.62; RD = 4.9 pp), disability (20.9% versus 30.2%; RR = 0.65, 95% CI 0.53, 0.79; RD = 9.3 pp), and death (1.8% versus 3.1%; RR = 0.52, 95% CI 0.28, 0.96; RD = 1.3 pp). Limitations include the relatively short study duration of only 1 year and the generalizability of our findings beyond the study setting. CONCLUSIONS: In this study, a primary care-based mobile health intervention integrating provider-centered and patient-facing technology was effective in reducing BP and improving stroke secondary prevention in a resource-limited rural setting in China. TRIAL REGISTRATION: ClinicalTrials.gov NCT03185858.
引用
- Yan LL, Gong E, Gu W, et al. Effectiveness of a primary care-based integrated mobile health intervention for stroke management in rural China (SINEMA): A cluster-randomized controlled trial. PLoS Med. 2021. PMID: 33909607. doi:10.1371/journal.pmed.1003582
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。